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Obesity is a condition characterized by adipose tissue hypertrophy; it is
estimated that the obesity epidemic accounted for 4 million deaths in 2015
and that 70% of these were due to cardiovascular disease (CVD). One of
the mechanisms linking obesity to CVD is the ability of adipose tissue to
secrete circulating factors. We hypothesized that adipose tissue and its
secretory products may influence mineralocorticoid receptor (MR) expres-
sion. Here, we showed that expression of MR and its downstream targets
(Cnksr3, Scnn1b, and Sgk1) were significantly reduced in the kidneys of
peroxisome proliferator-activated receptor-c null (PpargD/D) and A-ZIP/F-1
(AZIPtg/+) lipoatrophic mice with respect to their controls. Intriguingly,
MR expression was also found to be significantly reduced in the kidneys of
genetically obese ob/ob mice. Our data suggest that adipose tissue con-
tributes to the regulation of MR expression. Given that leptin deficiency
seems to be the major feature shared by PpargD/D, AZIPtg/+, and ob/ob
mice, we speculate that adipose tissue modulates MR expression through
the leptin system.
Obesity is a condition characterized by adipose tissue
hypertrophy, whose prevalence is increasing worldwide.
It is estimated that the obesity epidemic accounted for
4 million deaths in 2015, and that 70% of them were due
to cardiovascular disease (CVD) [1]. One of the mecha-
nisms linking obesity to CVD is the ability of the adipose
tissue to secrete circulating factors leading to organ dam-
age. In obesity, for example, there is an activation of adi-
pose renin–angiotensin–aldosterone system (RAAS),
with subsequent activation of systemic RAAS, ultimately
promoting CVD [2,3]. Consistent with this, obese patients
exhibit higher levels of aldosterone, which have been asso-
ciated with a greater risk for cardiometabolic disease [3].
Aldosterone is a mineralocorticoid hormone that is
primarily synthetized in the adrenal cortex. Its biologi-
cal actions are mediated by the mineralocorticoid
receptors (MR), which are located in epithelial and
nonepithelial tissues. After binding to MR, aldosterone
does not only lead to sodium reabsorption in the kid-
ney, whereby it regulates blood pressure, but it also
promotes widespread organ damage [4].
Mouse strains with lipoatrophy, which is a general-
ized loss of adipose tissue, have been used to under-
stand the role of white adipose tissue in health and
disease states. These strains include the peroxisome
proliferator-activated receptor-c (PPARc) null [5,6]
and the A-ZIP/F-1 mice [7]. In PPARc null mice,
lipoatrophy is due to the lack of PPARc, which is
essential for adipose tissue development [5]. In A-ZIP/
F-1 mice, the adipose-selective expression of a domi-
nant negative protein, A-ZIP/F, impairs normal adipo-
cyte growth and differentiation [7].
Abbreviations
CVD, cardiovascular disease; ENaC, epithelial Na channel; MR, mineralocorticoid receptor; Nr3c2, nuclear receptor subfamily 3 group C
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We hypothesized that adipose tissue and its secre-
tory products could influence MR regulation. To test
this hypothesis, we evaluated the renal expression of
MR in mouse models of lipoatrophy and compared it
with that of mouse models of obesity.
Materials and methods
Animal models
Female PPARc null (PpargD/D) mice were generated in our
laboratory as previously described [5,6]. Littermates with a
mixed C57BL/6J 9 129 genetic background and two func-
tional Pparg alleles were used as controls (CTL). Female
A-ZIP/F-1 mice (AZIPtg/+) and their wild-type controls on
a FVB/N background (FVB/N), which were a kind gift
from C. Vinson, were generated as previously reported [7].
Female B6.V-Lepob/J (ob/ob) mice and their controls
(C57BL/6J) were purchased from Charles River (Saint Ger-
main Nuelles, France).
Mice were followed for different time-periods and sacri-
ficed by CO2 inhalation. Kidneys were homogenized for
protein extraction or snap frozen for RNA analysis. Skin
samples were snap frozen in 1 mL of TRI-reagent/sample
(Thermo Fisher Scientific, Waltham, MA, USA). Leptin
was measured by ELISA (R&D, Minneapolis, MN, USA;
MOB00); creatinine, glucose, and plasma aldosterone were
measured at the Nephrology Service (CHUV, Switzerland).
Animal care and treatments were carried out in compliance
with specific European laws (86/609/EEC). This study was
approved by the Commission for Animal Experimentation
of the Cantonal Veterinary Services (Canton of Vaud).
Quantitative real-time RT-PCR
Total RNA from kidney was isolated with TRI-Reagent
and RNeasy Mini Kit (Qiagen, Hilden, Germany). Gene
expression of Nr3c2 and downstream mediators (Cnksr3,
Scnn1b, Sgk1) was analyzed by real-time quantitative PCR
(FastStart Universal SYBR Green Master; Roche, Pleasan-
ton, CA, USA) in a Stratagene MX3005P Detection System
(Agilent Technologies, Santa Clara, CA, USA). Rps9 was
used as the housekeeping gene. Primer sequences are avail-
able in Table 1.
Western blot
Fresh kidney samples were manually homogenized in ice-
cold TEN buffer containing protease inhibitors. After cen-
trifugation, cells were resuspended in buffer A (10 mM
HEPES pH 7.9, 10 mM KCl, 0.1 mM EGTA pH8, 0.1 mM
EDTA, 1 mM DTT) and subsequently lysed by the addition
of 10% NP-40. The homogenate was centrifuged, and the
supernatant containing the cytoplasmic fraction was col-
lected and stored at 80 °C. The pellet was then resus-
pended in nuclear extraction buffer, put on ice, and mixed
periodically for 20 min. After centrifugation, the super-
natant containing the nuclear fraction was stored at 80 °C.
Protein quantification was performed by BCA protein
assay kit (Thermo Scientific). Cytosolic and nuclear frac-
tions were subjected to SDS/PAGE and blotted onto nitro-
cellulose filters. After blocking, the membranes were
incubated with primary antibodies for MR (MRN 2B7, a
kind gift from C. Gomez-Sanchez), followed by peroxidase-
conjugated goat anti-mouse secondary antibodies.
Table 1. List of primers.
Gene Primer pair
Mouse
Rps9 (F) 50-GACCAGGAGCTAAAGTTGATTGGA-30
(R) 50-TCTTGGCCAGGGTAAACTTGA-30
Nr3c2 (F) 50-TCCTTTCCGCCTGTCAATG-30
(R) 50-GAGGATCCAGTAGAAACACTTCG-30
Cnksr3 (F) 50-GACTCCTGTCGATTGCCTAG-30
(R) 50-TCTCCCGCTCAAACTTGTG-30
Scnn1b (F) 50-CCCTGATCGCATAATCCTAGC-30
(R) 50-ATGCCCCAGTTGAAGATGTAG-30
Sgk1 (F) 50-CTTATGAACGCTAACCCCTCTC-30
(R) 50-GAACCTTTCCAAAACTGCCC-30
Table 2. General characteristics of the mice studied.
Parameters CTL PpargD/D FVB/N AZIPtg/+ C57BL/6J ob/ob
Age (weeks) 3 3 3 3 8 8
Body weight (g) 11.6  0.3 7.8  0.2‡ 12.6  0.5 8.7  0.7‡ 20.6  0.7 39.7  0.6‡
Index of renal hypertrophy [(g/
g) 9 100]
1.26  0.02 1.62  0.04‡ 1.18  0.03 1.37  0.03† 0.75  0.01 1.23  0.02‡
Plasma creatinine (lmol/L) 10.3  0.2 10.9  0.6 13.0  0.4 14.1  1.1 15.9  1.8 21.2  7.1
Glycemia (mmol/L) 10.1  0.2 16.4  1.5‡ 12.2  0.3 16.3  0.9† 9.0  0.1 14.5  1.7†
Leptin (pg/mL) 1484.0  491.0 121.4  71.1* 1808.2  344.3 205.3  65.1† 1250.0  629.6 Undetectable
Aldosterone (pg/mL) 467.4  87.5 785.5  179.5 492.6  100.2 835.5  255.4 347.2  25.5 382.8  30
Data are presented as mean  SEM (n = 4–11). *P < 0.05, †P < 0.01, ‡P < 0.0001 PpargD/D vs. CTL, AZIPtg/+ vs. FVB/N, or ob/ob vs.
C57BL/6J (Student’s t-test).
329FEBS Open Bio 9 (2019) 328–334 ª 2018 The Authors. Published by FEBS Press and John Wiley & Sons Ltd.
B. Toffoli et al. Renal MR in lipoatrophy
330 FEBS Open Bio 9 (2019) 328–334 ª 2018 The Authors. Published by FEBS Press and John Wiley & Sons Ltd.
Renal MR in lipoatrophy B. Toffoli et al.
Immunoreactivity was detected using the Supersignal West
Pico chemiluminescent substrate (Thermo Scientific). b-
Actin (Sigma-Aldrich, St. Louis, MO, USA), GAPDH (Cell
Signaling Technology, Danvers, MA, USA), and U2AF
(Sigma-Aldrich) were used as loading controls.
Statistical analysis
Values, expressed as mean  SEM, were analyzed using
PRISM 5.0 (GraphPad Software, San Diego, CA, USA).
Student’s t-test was used to assess statistical significance. A
P value < 0.05 was considered statistically significant.
Results
MR expression is significantly reduced in the
kidneys of PpargD/D and AZIPtg/+ mice
The general characteristics of the animal studied are
reported in Table 2. Lipoatrophy was associated with
Fig. 2. Skin MR expression and
aldosterone levels in lipoatrophic mice. (A)
Skin Nr3c2 expression evaluated by RT-
qPCR in CTL and PpargD/D (cD/D) mice at
different time points (P1, P8, P17, and
P28 days) after birth (n = 3–5). Data show
mean  SEM. Student’s t-test was used
to assess statistical significance. (B)
Box plots represent plasma aldosterone
evaluated at 3 and 13 weeks of age in
CTL, PpargD/D (cD/D), FVB/N, and AZIPtg/+
female mice (n = 5). Student’s t-test was
used to assess statistical significance.
Fig. 1. MR is downregulated in kidneys of lipoatrophic mice. (A) Renal Nr3c2 (MR gene) expression evaluated by RT-qPCR in CTL and
PpargD/D (cD/D) mice at 3 and 52 weeks of age (n = 5–11). (B) Renal Nr3c2 expression in FVB/N and AZIPtg/+ animals at 3 and 13 weeks of
age (n = 4–8). Results in PpargD/D and AZIPtg/+ mice are expressed as fold modulation with respect to their related littermate levels, which
were arbitrarily set to 1. Data show mean  SEM. **P < 0.01, ***P < 0.0001 PpargD/D and AZIPtg/+ vs. CTL or FVB/N, respectively
(Student’s t-test). (C) Representative blots and densitometric analysis of MR protein in the renal cytosolic fraction of 3-week-old CTL,
PpargD/D (cD/D), FVB/N, and AZIPtg/+ mice. Data, normalized to b-actin or GAPDH, are expressed as mean  SEM (n = 3). (D) Nuclear MR
protein expression in kidneys of the same groups of mice. Data, normalized to U2AF, are expressed as mean  SEM (n = 3–4). *P < 0.05,
**P < 0.01 PpargD/D and AZIPtg/+ vs. relative control animals (Student’s t-test). (E) Renal expression of Cnksr3, (F) Scnn1b, and (G) Sgk1 in
CTL, PpargD/D (cD/D), FVB/N and AZIPtg/+ mice at 3 weeks of age (n = 6–11). Data show mean  SEM. *P < 0.05, **P < 0.01 PpargD/D and
AZIPtg/+ vs. CTL or FVB/N, respectively (Student’s t-test).
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body weight and leptin reduction, as well as kidney
hypertrophy [5,6]. Interestingly, 3-week-old PpargD/D
and AZIPtg/+ mice exhibited a significant downregula-
tion of MR gene (Nr3c2) expression in their kidneys,
which was also observed in older animals (Fig. 1A,B).
Similar results were found in the skin, suggesting that
MR gene downregulation was tissue-independent
(Fig. 2A). The reduction of MR gene expression was
associated with a significant reduction of cytosolic and
nuclear MR protein levels, as assessed by western blot
analysis, in the kidneys of 3-week-old lipoatrophic
mice with respect to their controls (Fig. 1C,D).
Downstream targets of MR are significantly
reduced in the kidneys of PpargD/D and AZIPtg/+
mice
Classically, when aldosterone binds to MR, it increases
renal sodium reabsorption by upregulating the epithe-
lial Na channel (ENaC) and the sodium/potassium
ATPase (Na-K-ATPase) in the collecting duct system
[3]. Cnksr3, Scnn1b, and Sgk1 are involved in this
aldosterone-mediated ENaC modulation through MR
activation [8,9]. Consistent with the MR reduction,
Cnksr3 and Scnn1b were downregulated in both
PpargD/D and AZIPtg/+ mice, and Sgk1 was reduced in
PpargD/D mice (Fig. 1E–G). Conversely, both lipoat-
rophic models exhibited a progressive increase of
aldosterone plasma levels, possibly due to the decrease
of its specific receptor (Fig. 2B).
MR expression is significantly decreased in the
kidneys of ob/ob mice
To evaluate whether renal MR reduction in lipoat-
rophic mice was due to the absence of fat, we mea-
sured MR expression in the kidneys of ob/ob mice, a
model of extreme obesity, due to a mutation of the
gene encoding for leptin [10,11]. The general character-
istics of these mice are reported in Table 2. Interest-
ingly, we found that ob/ob mice displayed a significant
reduction of both cytosolic and nuclear MR expression
(Fig. 3A,B). Contrary to lipoatrophic mice, this was
not associated with significant changes in aldosterone
levels and/or the gene expression of Cnksr3, Scnn1b,
and Sgk1 (Fig. 3C–E).
Discussion
This study shows that renal MR is significantly
reduced not only in lipoatrophic mice but also in a
mouse model of extreme obesity. Notwithstanding the
presence of minor interstrain differences, our data sug-
gest that the adipose tissue contributes to the regula-
tion of renal MR expression, which seems related to
adipose tissue function, rather than adipose tissue
mass per se. Typically, adipose tissue dysfunction
includes not only visceral (ectopic) fat accumulation
(as seen in lipoatrophy), but also changes in its com-
position as well as in mRNA and protein expression
patterns (as seen in ob/ob mice) [12].
Fig. 3. MR is downregulated in kidneys of
ob/ob mice. (A) Representative blots and
densitometric analysis of MR protein in
the renal cytosolic fraction of 8-week-old
ob/ob and control (C57BL/6J) mice. Data
are normalized to b-actin and expressed as
mean  SEM (n = 4). (B) Nuclear MR
protein expression in kidneys of the same
groups of mice. Data are normalized to
U2AF and expressed as mean  SEM
(n = 4). **P < 0.01 ob/ob vs. control
animals (Student’s t-test). (C) Renal
expression of Cnksr3, (D) Scnn1b, and (E)
Sgk1 in C57BL/6J and ob/ob mice at
8 weeks of age. Data show mean  SEM
(n = 4–5) (Student’s t-test).
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In healthy conditions, adipocytes are metabolically
active cells that secrete a wide variety of hormones
and adipokines, such as leptin, which regulates several
physiological functions [13] by binding to its specific
receptors in different tissues, including kidney and skin
[14,15]. Interestingly, leptin deficiency has been associ-
ated with insulin resistance, diabetes, and organ dam-
age in humans and animals [5,13]. In addition,
although transgenic overexpression of leptin and fat
transplantation rescued the metabolic disorders in
lipoatrophic AZIPtg/+ mice [16,17], the transplantation
of adipose tissue from ob/ob mice was unable to
reverse AZIPtg/+ diabetes phenotype, thus underlying
the fundamental role of leptin and its signaling in
maintaining body homeostasis [18].
Adipocytes produce [19] and regulate aldosterone
release as well. In particular, Ehrhart-Bornstein
observed that adipocytes isolated from healthy subjects
secreted potent mineralocorticoid-releasing factors,
with a major effect on aldosterone release [20]. It has
been shown that leptin is one of these mineralocorti-
coid-releasing factors, as it was able to directly regu-
late aldosterone secretion from the adrenal cortex,
independent of angiotensin, and the sympathetic ner-
vous system [21]. Given that leptin deficiency seems
the major feature that PpargD/D, AZIPtg/+, and ob/ob
mice have in common, we speculate that adipose tissue
modulates renal MR expression through leptin or a
leptin-regulated factor. This is consistent with the
observation that in high-fat diet-induced obesity,
which is associated with an increase of circulating lep-
tin levels [22], there is an increase in the renal nuclear
fraction of MR [23].
The stimulatory effect that leptin might have on
renal MR expression could be an additional way that
leptin has to promote aldosterone actions. Further
studies are needed to evaluate the effect of leptin
replenishment on MR expression in these mouse mod-
els of leptin deficiency. Nevertheless, our data support
the relationship between fat, aldosterone, and CVD;
improve the understanding; and open new possibilities
for the management of obesity-related disease burden.
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